- Home
- PDLB vs LRMR Comparison
PDLB vs LRMR Comparison
Compare PDLB & LRMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDLB
- LRMR
- Stock Information
- Founded
- PDLB 1960
- LRMR N/A
- Country
- PDLB United States
- LRMR United States
- Employees
- PDLB N/A
- LRMR N/A
- Industry
- PDLB
- LRMR Biotechnology: Pharmaceutical Preparations
- Sector
- PDLB
- LRMR Health Care
- Exchange
- PDLB Nasdaq
- LRMR Nasdaq
- Market Cap
- PDLB 330.3M
- LRMR 309.8M
- IPO Year
- PDLB 2017
- LRMR N/A
- Fundamental
- Price
- PDLB $14.54
- LRMR $4.82
- Analyst Decision
- PDLB
- LRMR Strong Buy
- Analyst Count
- PDLB 0
- LRMR 7
- Target Price
- PDLB N/A
- LRMR $16.71
- AVG Volume (30 Days)
- PDLB 40.4K
- LRMR 4.7M
- Earning Date
- PDLB 10-29-2025
- LRMR 10-29-2025
- Dividend Yield
- PDLB N/A
- LRMR N/A
- EPS Growth
- PDLB 83.78
- LRMR N/A
- EPS
- PDLB 0.71
- LRMR N/A
- Revenue
- PDLB $90,513,000.00
- LRMR N/A
- Revenue This Year
- PDLB $10.97
- LRMR N/A
- Revenue Next Year
- PDLB $8.59
- LRMR N/A
- P/E Ratio
- PDLB $20.47
- LRMR N/A
- Revenue Growth
- PDLB 15.50
- LRMR N/A
- 52 Week Low
- PDLB $10.88
- LRMR $1.61
- 52 Week High
- PDLB $15.21
- LRMR $9.50
- Technical
- Relative Strength Index (RSI)
- PDLB 48.56
- LRMR 57.10
- Support Level
- PDLB $14.47
- LRMR $4.52
- Resistance Level
- PDLB $14.85
- LRMR $4.99
- Average True Range (ATR)
- PDLB 0.21
- LRMR 0.52
- MACD
- PDLB -0.04
- LRMR 0.04
- Stochastic Oscillator
- PDLB 46.48
- LRMR 73.57
About PDLB Ponce Financial Group Inc.
Ponce Financial Group Inc, is a United States-based holding company. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in mortgage loans, consisting of one-to-four-family residential, multi-family residential, non-residential property and construction and land, and, to a lesser extent, business, and consumer loans. The company also invests in securities, which consists of securities issued by the U.S. Government and federal agencies and mortgage-backed securities issued by the United States government-sponsored enterprises. Some of the products and services include checking solutions, online and mobile banking, merchant credit card services, and others.
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.